Back to Authors

Louissaint, Abner

0000-0001-6707-917X

Mayo Clinic

Massachusetts General Hospital Cancer Center, Boston, MA.

Citations 1

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Blood | July 8, 2022 | Volume: 140 | Issue: 16 | Pages: 1822-1826

10.1182/blood.2022015443 | PMID 35802834